search icon
  • Print
  • ShareThis
  • Text Size
  • Hepatitis C

    Hepatitis Header

    Viral hepatitis is a silent epidemic. According to the United States Department of Health and Human Services, it is estimated that 2.7 to 3.9 million persons are infected with the hepatitis C virus (HCV) in the United States alone. An enormous public health danger lies in the fact that many infected patients are unaware of their diseased state. HCV's slow disease progression can lead to liver cirrhosis or hepatocellular carcinoma, which ultimately requires transplantation or causes mortality.


    Up-to-date guidance for the treatment of HCV infection from IDSA and AASLD.

    Clinical Guidance

    Guidelines from Department of Veterans Affairs, AASLD, and AGA on recommended steps to properly treat hepatitis C patients.

    Educational Resources

    Hepatitis C presentations, research documents, and CME links for ID clinicians.

    Management of Hepatitis C

    Resources for the proper management of hepatitis C and associated complications.

    Information for Healthcare Personnel Potentially Exposed to Hepatitis C Virus

    Exposure to viral hepatitis has long been recognized as an occupational risk for healthcare personnel, with recommendations previously established for the management of occupational exposures to hepatitis C virus (HCV). This notice, which is based on current laboratory guidance, updates the 2001 HCV testing algorithm for healthcare personnel.

    Living with Hepatitis C

    Resources to help hepatitis C patients find IDSA-approved medical information and support networks.

    Finding Treatment

    Federally qualified clinic directories and a list of state health department hepatitis resources.

    The Silent Pandemic: Tackling Hepatitis C with Policy Innovation (PDF)

    The silent pandemic: Tackling hepatitis C with policy innovation is an Economist Intelligence Unit report, supported through an educational grant by Janssen, which investigates the health challenge posed by the hepatitis C virus (HCV), and how systemic innovation can minimize its impact. The findings of this white paper are based on desk research and interviews with a range of healthcare experts.

    CDC Recommendations for Screening of Persons Born During 1945-1965 for Chronic Hepatitis C Virus Infection (PDF)

    Research has determined that the population born between 1945 and 1965 is five times more likely to test positive for hepatitis C antibodies. This recommendation presents information concerning testing, management, and future endeavors to decrease to spread of hepatitis C.

    Hepatitis C Virus Infection Testing Diagnosis Algorithm (PDF)

    The Centers for Disease Control and Prevention has developed an algorithm that will guide physicians on subsequent actions after a patient is positive for hepatitis C antibodies.

    Reference for Interpretation of Hepatitis C Virus Test Results (PDF)

    The Centers for Disease Control and Prevention makes available a chart on how to interpret hepatitis C test results and any subsequent additional tests that may be required to obtain a comprehensive diagnosis.

    Hepatitis Surveillance Report

    Preliminary data shows that in over just five years, the number of new hepatitis C infections reported to CDC has nearly tripled, reaching a 15-year high. The greatest increases, and the highest overall number of cases, were among young people 20-29, with injection drug use as the primary route of transmission. However, the majority (three-quarters) of the 3.5 million Americans already living with hepatitis C are baby boomers, born from 1945 to 1965, who are six times more likely to be infected with hepatitis C than those in other age groups and are at much greater risk for death from the virus.

| HIVMA | Contact Us

© Copyright IDSA 2018 Infectious Diseases Society of America

Full Site Mobile Site